---
title: "Clear Street Keeps Their Buy Rating on Summit Therapeutics (SMMT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294675816.md"
description: "Clear Street analyst maintained a Buy rating on Summit Therapeutics today and set a price target of $31.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In addition to Clear Street, Summit Therapeutics also received a Buy from Goldman Sachs’s Salveen Richter in a report issued on July 28. However, on July 24, H.C. Wainwright reiterated a Hold rating on Summit Therapeutics (NASDAQ: SMMT)."
datetime: "2026-08-03T10:05:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294675816.md)
  - [en](https://longbridge.com/en/news/294675816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294675816.md)
generator: "portal-rs"
---

# Clear Street Keeps Their Buy Rating on Summit Therapeutics (SMMT)

Clear Street analyst maintained a Buy rating on Summit Therapeutics today and set a price target of $31.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In addition to Clear Street, Summit Therapeutics also received a Buy from Goldman Sachs’s Salveen Richter in a report issued on July 28. However, on July 24, H.C. Wainwright reiterated a Hold rating on Summit Therapeutics (NASDAQ: SMMT).

### Related Stocks

- [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Summit Therapeutics strengthened by positive ivonescimab survival results](https://longbridge.com/en/news/297927190.md)
- [Summit Therapeutics Stock (SMMT) Rallies on Positive Clinical Trial Results](https://longbridge.com/en/news/297937944.md)
- [AcuCort notifies availability of August 2026 newsletter press release](https://longbridge.com/en/news/297505730.md)
- [These Were The Best And Worst Performing Assets Of August](https://longbridge.com/en/news/297728245.md)
- [Here's How Much $100 Invested In Lumentum Holdings 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/297965936.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**